SHIFT Newsroom · GLOBAL
Dual GIP/GLP-1 Receptor Agonist Being Investigated for Obese Women Before Frozen Embryo Transfer
A clinical trial is underway to study the effects of a Dual GIP/GLP-1 Receptor Agonist in obese women before frozen embryo transfer.
A clinical trial is underway to study the effects of a Dual GIP/GLP-1 Receptor Agonist in obese women before frozen embryo transfer. The trial is registered on ClinicalTrials.gov and is currently in the early stages. More evidence is needed to determine the effectiveness and safety of the Dual GIP/GLP-1 Receptor Agonist.
What this means in the UK
This trial may have implications for the treatment of obesity and fertility in the UK, but it is still in the early stages and more evidence is needed to determine its effectiveness and safety.
Known facts
- A clinical trial is underway to study the effects of a Dual GIP/GLP-1 Receptor Agonist in obese women before frozen embryo transfer.